AtriCure
ATRC
55.39
+1.28
+2.37%
AtriCure
US · ATRC
#2543 by market cap
Listed 1970
55.39
+1.28
+2.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Company notice
Atreca | 8-K: Atreca Reports Fourth Quarter and Full-Year 2021 Financial Results and ATRC-101 Data UpdateSEC · 2022/3/4
-
Rating change
Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/7/24
-
Rating change
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Prime Medicine, Inc. (PRME) and Community Health (CYH)TipRanks · 2026/7/24
-
Rating change
UBS Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $50Market Newswire · 2026/7/28
-
Rating change
Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/7/24
-
Rating change
Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/7/24
-
Company notice
Atreca | 8-K: Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data UpdateSEC · 2023/3/30
-
Rating change
Oppenheimer Maintains AtriCure(ATRC.US) With Hold RatingMarket Newswire · 2026/7/24
-
Rating change
BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/7/24
-
Rating change
BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $55Market Newswire · 2026/8/24
-
Rating change
Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $65Market Newswire · 2026/9/17
-
Rating change
Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $60Market Newswire · 2026/8/27
-
BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $63Market Newswire · 2026/10/12
-
Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/11/12
-
Rating change
Freedom Capital Markets Downgrades AtriCure(ATRC.US) to Hold Rating, Raises Target Price to $57Market Newswire · 2026/10/2
-
Citizens JMP Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $68Market Newswire · 2026/10/21
-
A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $62 to $70Market Newswire · 2026/11/5
-
Rating change
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/8/12
-
Earnings Flash (ATRC) AtriCure, Inc. Posts Q3 Adjusted EPS $0.17 per Share, Vs. FactSet Est of $-0.06MT Newswires · 2026/11/4
-
Rating change
Needham Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $64Market Newswire · 2026/9/2
-
Rating change
Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45Market Newswire · 2026/7/13
-
Rating change
BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Cuts Target Price to $45Market Newswire · 2026/5/6
-
Rating change
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $55Market Newswire · 2026/5/6
-
Rating change
BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $54Market Newswire · 2026/2/18
-
Rating change
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Atricure (ATRC) and Tempus AI, Inc. Class A (TEM)TipRanks · 2026/5/6
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
AtriCure discussion 0 comments